More on CTNM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $12.16 |
|
|||
| Open | $12.30 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $12.67 | ||||
| Day Low | $11.57 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 313,870 | ||||
- Form 4 Contineum Therapeutics, For: Jun 01 Filed by: Lorrain Daniel S.
- Form 144 Contineum Therapeutics, Filed by: Lorrain Daniel S.
- Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference
- Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
- Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Form SCHEDULE 13G Contineum Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
- Contineum Therapeutics (CTNM) PT Raised to $16 at Morgan Stanley
- Contineum Therapeutics to Present at the 2026 RBC Capital Markets Global Healthcare Conference
- Contineum Therapeutics Announces Two Upcoming Posters at the American Thoracic Society (ATS) 2026 International Conference
- Contineum Therapeutics, Inc. (CTNM) Tops Q1 EPS by 46c
Entities mentioned with CTNM
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Stifel | View Related Stories »
- FDA | View Related Stories »
- RBC Capital | View Related Stories »
- Show More...
